EMBOLEX Side Effects

6027900-3 | Constipation, Convulsion, Nausea, Oral Candidiasis, Restlessness, Skin Disorder, Sleep Disorder, Stevens-johnson Syndrome, Transient Ischaemic Attack
on Dec 11, 2008 Female patient from GERMANY , 84 years of age, was diagnosed with thrombosis prophylaxis, pruritus, pain (What is pain?), convulsion, sleep disorder (What is sleep disorder?), nausea (What is nausea?) and was treated with Embolex (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), convulsion, nausea (What is nausea?), oral candidiasis, restlessness, skin disorder, sleep disorder (What is sleep disorder?), stevens-johnson syndrome, transient ischaemic attack. Embolex dosage: 0.5 Mg, Qd, Subcutaneous. During the same period patient was treated with VOLTAREN (1 Df, Bid, Oral) (View Voltaren Review and Voltaren Label ), PHENHYDAN (PHENYTOIN) 100 MG (1 Df, Tid, Oral) (View Phenhydan (phenytoin) 100 Mg Review and Phenhydan (phenytoin) 100 Mg Label ), COTRIM FORET ^HEUMANN^ (SULFAMETHOXAZOLE, TRIMETHOPRIM) (1 Df, Qd, Oral) (View Cotrim Foret ^heumann^ (sulfamethoxazole, Trimethoprim) Review and Cotrim Foret ^heumann^ (sulfamethoxazole, Trimethoprim) Label ), TEMAZEPAM (1 Df, Bid, Oral) (View Temazepam Review and Temazepam Label ), PASPERTIN / GFR/ (METOCLOPRAMIDE HYDROCHLORIDE) DROPS (15 Df, Tid, Oral) (View Paspertin / Gfr/ (metoclopramide Hydrochloride) Drops Review and Paspertin / Gfr/ (metoclopramide Hydrochloride) Drops Label ), NOVALGIN / SCH/ (METAMIZOLE SODIUM MONOHYDRATE) DROPS (30 Df, Qid, Oral) (View Novalgin / Sch/ (metamizole Sodium Monohydrate) Drops Review and Novalgin / Sch/ (metamizole Sodium Monohydrate) Drops Label ). Patient was hospitalized.

5856410-9 | Dry Mouth, Dysphagia, Dyspnoea, Eating Disorder, Nasal Dryness, Weight Decreased
Patient was taking Embolex (View Usage). Patient had the following side effects: dry mouth, dysphagia, dyspnoea, eating disorder (What is eating disorder?), nasal dryness, weight decreased on Aug 22, 2008 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 148.0 lb, was diagnosed with hypertonic bladder and. Embolex dosage: .

5642623-8 | Constipation, Depression, Hip Arthroplasty, Hyperchlorhydria, Stevens-johnson Syndrome
Adverse event was reported on Feb 14, 2008 by a Male patient taking Embolex (View Usage) (Dosage: Subcutaneous) was diagnosed with thrombosis prophylaxis, polyarthritis, infection prophylaxis, pain (What is pain?), hypertension and. Location: GERMANY , 67 years of age, After Embolex was administered, patient had the following side effects: constipation (What is constipation?), depression (What is depression?), hip arthroplasty, hyperchlorhydria, stevens-johnson syndrome. During the same period patient was treated with METHOTREXATE (100 Mg/day, Oral) (View Methotrexate Review and Methotrexate Label ), AUGMENTIN I.V.(AMOXICILLIN SODIUM, CLAVULANATE POTASSIUM) 2.2G (1 Df, Tid, Intravenous) (View Augmentin I.v.(amoxicillin Sodium, Clavulanate Potassium) 2.2g Review and Augmentin I.v.(amoxicillin Sodium, Clavulanate Potassium) 2.2g Label ), OXYGESIC(OXYCODONE HYDROCHLORIDE) 20MG (Oral) (View Oxygesic(oxycodone Hydrochloride) 20mg Review and Oxygesic(oxycodone Hydrochloride) 20mg Label ), BAYOTENSIN(NITRENDIPINE) (1 Df, Bid, Oral) (View Bayotensin(nitrendipine) Review and Bayotensin(nitrendipine) Label ), CAPTOPRIL (Oral) (View Captopril Review and Captopril Label ), HYDROCHLOROTHIAZIDE (Oral) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

5020715-4 | Blood Creatinine Increased, Compartment Syndrome, Haematoma, Myoglobin Blood Increased, Paraesthesia, Post Procedural Complication
on May 18, 2006 Female patient from GERMANY , 85 years of age, weighting 169.8 lb, was diagnosed with thrombosis and was treated with Embolex (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, compartment syndrome, haematoma, myoglobin blood increased, paraesthesia, post procedural complication. Embolex dosage: 8000 Iu, Bid, Subcutaneous. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (1 Df, Qd) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), AMLOCARD 10 (AMLODIPINE BESILATE) (View Amlocard 10 (amlodipine Besilate) Review and Amlocard 10 (amlodipine Besilate) Label ), COAPROVEL (HYDROCHLOROTHIAZIDE, IRBESARTAN) (View Coaprovel (hydrochlorothiazide, Irbesartan) Review and Coaprovel (hydrochlorothiazide, Irbesartan) Label ), PENTAERYTHIRITOL TETRANITRATE TAB (View Pentaerythiritol Tetranitrate Tab Review and Pentaerythiritol Tetranitrate Tab Label ), TORACARD 10 (TORASEMIDE) (View Toracard 10 (torasemide) Review and Toracard 10 (torasemide) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.


4947859-7 | Anaemia, Anti-platelet Antibody Positive, Fall, Intra-abdominal Haemorrhage
on Mar 01, 2006 Female patient from GERMANY , 79 years of age, weighting 132.3 lb, was diagnosed with thrombosis and was treated with Embolex (View Usage). Patient had the following side effects: anaemia, anti-platelet antibody positive, fall (What is fall?), intra-abdominal haemorrhage. Embolex dosage: 7800 Iu, Bid, Subcutaneous. During the same period patient was treated with ACETYLSALICYLIC ACID (NGX) (ACETYLSALICYLIC ACID) 100MG (100 Mg, Qd (o.m)) (View Acetylsalicylic Acid (ngx) (acetylsalicylic Acid) 100mg Review and Acetylsalicylic Acid (ngx) (acetylsalicylic Acid) 100mg Label ). Patient was hospitalized.